🇺🇸 FDA

Intelligence · Drug directory

Withdrawn Drug Applications

Drugs with withdrawn or discontinued regulatory applications in the US or EU — useful for competitive and label-history research.

Quick answer

Withdrawn applications: NovaPharmaNews tracks 229 pharmaceutical drugs in this segment. Drugs with withdrawn or discontinued regulatory applications in the US or EU — useful for competitive and label-history research.

229 drugs · Withdrawn · by data quality · Page 2 of 10

  1. nateglinide

    TRAZEC Teva Pharma GmbH

    ORAL FDA: approved · EMA: withdrawn

    A10BX03

  2. omacetaxine mepesuccinate

    TEKINEX Teva Pharma GmbH

    SUBCUTANEOUS FDA: approved · EMA: application withdrawn

    L01XX40

  3. peginesatide

    OMONTYS Takeda

    EMA: application withdrawn

    B03XA

  4. peramivir

    ALPIVAB Biocryst

    INTRAVENOUS FDA: approved · EMA: withdrawn

    J05AH03

  5. pralsetinib

    GAVRETO RIGEL PHARMACEUTICALS INC

    ORAL FDA: approved · EMA: withdrawn

    L01EX23

  6. retapamulin

    ALTARGO Almirall, S.A.

    TOPICAL FDA: approved · EMA: withdrawn

    D06AX13

  7. ribavirin

    RIBAVIRIN BIOPARTNERS Teva Pharma GmbH

    ORAL FDA: approved · EMA: withdrawn · PMDA: approved

    J05AP01

  8. rilonacept

    RILONACEPT FGK REPRESENTATIVE SERVICE GMBH Regeneron UK Limited

    SINGLE-USE FDA: approved · EMA: application withdrawn

    L04AC04

  9. salmeterol xinafoate

    AIREXAR SPIROMAX Teva Pharma GmbH

    INHALATION FDA: approved · EMA: withdrawn

    R03AK06

  10. sodium benzoate

    PROHIPPUR MAIA Biotechnology

    ORAL FDA: approved · EMA: application withdrawn

    A16AX11

  11. sotagliflozin

    ZYNQUISTA LEXICON PHARMACEUTICALS, INC.

    ORAL FDA: approved · EMA: withdrawn

    A10

  12. sugammadex sodium

    SUGAMMADEX LORIEN Teva Pharma GmbH

    INJECTION FDA: approved · EMA: application withdrawn · PMDA: approved

    V03AB35

  13. telavancin

    VIBATIV Theravance Biopharma Ireland Umited

    INJECTION FDA: approved · EMA: withdrawn

    J01XA03

  14. testosterone

    ANDROFORTE 5 Lacuna Pharma Pty Ltd

    IMPLANTATION FDA: approved · EMA: withdrawn · TGA: approved

    G03BA03

  15. treprostinil diolamine

    OREPAXAM United Therapeutics Europe Ltd

    ORAL FDA: approved · EMA: application withdrawn

    B01AC21

  16. treprostinil sodium

    TYVASO United Therapeutics Europe Ltd

    INHALATION FDA: approved · EMA: application withdrawn

  17. zaleplon

    SONATA Teva Pharma GmbH

    ORAL FDA: approved · EMA: withdrawn

    N05CF03

  18. adefovir dipivoxil

    HEPSERA

    ORAL FDA: approved · EMA: withdrawn

    J05AF08

  19. albiglutide

    EPERZAN

    INJECTION FDA: approved · EMA: withdrawn

    A10BJ04

  20. aliskiren hemifumarate

    RASILAMLO

    ORAL FDA: approved · EMA: withdrawn

    C09XA53

  21. alitretinoin

    PANRETIN

    TOPICAL FDA: approved · EMA: withdrawn

    L01XX22

  22. amikacin sulfate

    ARIKAYCE

    INJECTION FDA: approved · EMA: application withdrawn

    J01GB06

  23. amprenavir

    AGENERASE

    ORAL FDA: approved · EMA: withdrawn

    J05AE05

  24. becaplermin

    GEMESIS

    TOPICAL FDA: approved · EMA: withdrawn

    D03AX06

Frequently asked questions

How many withdrawn drugs are listed?

229 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.